Small-cap focus: UK biotechs seek to prosper in immunotherapy – Financial Times
Financial Times |
Small-cap focus: UK biotechs seek to prosper in immunotherapy
Financial Times But whatever lies in store for the UK pharma group, biotech companies a fraction of its size are poised to reap significant rewards from cancer treatments, not least in the field of immunotherapy drugs. MarketsandMarkets, a research provider, estimates … |
